Hyperion DeFi, Inc.

Hyperion DeFi, Inc. is a financial technology company specializing in decentralized finance (DeFi). Its primary function is to serve as the first publicly-listed U.S. firm to build and manage a strategic treasury comprised of HYPE, the native token of the Hyperliquid blockchain. The company’s transition from a digital ophthalmic technology background to DeFi is underscored by a focus on leveraging blockchain assets for yield generation, staking, and product development. Hyperion DeFi, Inc. aims to provide simplified, regulated public market access to the emerging Hyperliquid ecosystem, supporting growth within one of the world’s fastest-growing and highest revenue-generating decentralized blockchains. In addition to its crypto treasury initiatives, the company continues to develop the Optejet device, designed to enhance compliance and outcomes in ocular disease treatment. By combining DeFi strategies with proprietary medical technology development, Hyperion DeFi, Inc. holds a unique position at the intersection of digital finance and healthcare innovation, reflecting its evolving role in the broader financial market landscape.